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BACKGROUND. Although many articles on perforating veins have
been published, much knowledge about these veins is lacking.
OBJECTIVE. In this review relevant facts about the clinical
importance of perforating veins in venous disease are described.
METHODS. A literature search on English, French and German
articles has been performed using literature databases like
Medline, Embase and Cochrane.
RESULTS. Selection criteria are described.
CONCLUSION. A few conclusions are drawn: incompetent
perforating veins can be of haemodynamic importance,
especially in venous ulceration and (recurrent) varicose veins.
The current definition of incompetent perforating veins is reflux
more than 0,5 seconds (detected by Duplex ultra-sonography).
Good anatomical and clinical classifications are published and
should be integrated in the CEAP classification. Based on the
clinical classification treatment options are described for the
different types of incompetent perforating veins. Two different
treatment modalities for incompetent perforating veins are
surgery (SEPS) and sclerotherapy. SEPS seems to be of benefit in
patients with venous ulceration and advanced CVI. Sclero-
therapy (especially ultra sound guided sclerotherapy) is
promising and worth further evaluation.
P. A. F. A. VAN NEER, MD, PHD, J. C. J. M. VERAART, MD, PHD, AND H. A. M. NEUMANN, MD, PHD HAVE INDICATED
NO SIGNIFICANT INTEREST WITH COMMERCIAL SUPPORTERS.
THE FIRST author who demonstrated perforating veins
(PVs) in the lower leg was von Loder, a Russian
anatomist.1 Many anatomists and clinicians have since
then investigated PVs.2–8 PVs join the superficial
and deep veins of the lower leg and normally direct
the blood from the superficial to the deep venous
system. They are called PVs because they pierce
the fascia generalis. PVs are often duplicated. Along
with the PVs runs a small artery.9 PVs possess
valves (one to four valves) that are mostly located
subfascial.2 Anatomic studies showed that many PVs
with a diameter of less than 1 mm have no valves.10
Valveless PVs probably have no hemodynamic function.
The PVs are thought to play an important role
because of their valves in directing the blood flow from
the superficial network to the deep veins.11 They appear
to play the role of pressure valves when a sudden
marked increase in pressure occurs in a muscular
component. During this pressure increase, the valves
in the PV close, and this prevents blood flow from the
deep to the superficial system. During relaxation, the
pressure decreases, and the valves in the PVs open to
allow blood flow from the superficial into the deep
system. Although it has always been postulated that the
blood flow in PVs goes from the superficial veins to the
deep veins (so-called inward flow), it was Bjordal12,13
who first demonstrated bidirectional flow (inward and
outward flow) in PVs in patients with primary varicosis.
This bidirectional flow in patients with venous disease
was confirmed by others using duplex ultrasonogra-
phy.14,15 Bidirectional flow in PVs has also been
detected by duplex ultrasonography in persons with-
out any signs of venous disease,14,16 although others
could not confirm this.15
There are numerous PVs in each lower limb,
probably approximately 150, of variable length.17 In a
recent consensus document, a proposal was done to use
descriptive terms designating the location of PVs.18
According to this article, the PVs of the lower limbs can
be divided into six groups: PVs of the foot, ankle, leg,
knee, thigh, and gluteal muscles. From a clinical point
of view, there are four important locations for PVs: the
thigh, the upper medial part and the lower medial part
of the lower leg, and the knee fold.19 In the thigh, we
can find the clinical important inguinal perforators (also
called the saphenofemoral crosse), connecting the
greater saphenous vein (GSV) with the femoral vein in
the groin. More distally located in the thigh, the
perforators of the femoral canal (also called PVs of
Dodd or Hunter) are found, connecting the GSV with
the superficial femoral vein, although in some patients,
these PVs run different and have no connection with the
GSV.20 In the upper medial part of the lower leg, the
paratibial perforators (also called PVs of Sherman and
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Boyd) connect the GSV with the posterior tibial veins.
These PVs are a common site for the spontaneous
occurrence of primary and recurrent varicosis.19 On the
lower medial part of the lower leg, the posterior tibial
perforators (also called PVs of Cockett) are of clinical
importance. They connect the posterior accessory GSV
with the posterior tibial veins. This is the place where
most clinical symptoms of chronic venous insufficiency
(CVI) occur. The popliteal fossa perforator (also called
the parvapopliteal crosse) connects the short saphenous
vein with the popliteal vein.
Methods
A literature search on English, German, and French
publications has been performed on venae perforantes
or PVs using medical literature databases like Medline,
Embase, and Cochrane. Key words used are vena(e)
perforan(te)s, vena(e) communican(te)s, PVs and
communicating veins, perforan(te)s jambieres, and
perforierende vene(n). Reference lists of relevant
articles have been reviewed also for additional
citations, as were the entire review articles.
Selection criteria for all articles were defined as
follows: PVs should have been the main study objective.
Clinical aspects of PV should have been investigated.
Special attention should have been paid to the possible
influence of coexisting superficial incompetence, and
whenever the influence or relevance of incompetent PVs
(IPV) was investigated, the hemodynamic significance
of these IPV should have been investigated with
objective methods such as ambulatory venous pressure
(AVP), photo-, air- or strain-gauge plethysmography.
Evidence in intervention studies depended on the
following criteria: level 1 evidence, which was based
on one A1 study (defined as a meta-analysis of A2
studies in which the results of several A2 studies are
consistent) or two independent A2 studies (defined as
randomized, comparative, double-blinded, clinical stu-
dies); level 2 evidence, which was based on two
independent B studies (defined as randomized studies
of poor quality or other comparative studies like case
control, cohort); level 3 evidence, which was based on
one A2 or one B study or on C studies (defined as
noncomparative studies); and level 4 evidence, which
was the opinion of experts.
IPVs
On which criteria do phlebologists decide that a PV is
incompetent? There is no agreement about the
definition of IPV.10,15,16,21,22 The two criteria mostly
used to decide whether a PV is incompetent are reflux
and diameter. Reflux, or outward flow (defined as flow
from deep to superficial system), is considered to be
the most reliable criterion to decide whether a PV is
incompetent. Although it is known that reflux occurs
in healthy subjects as well, it has been shown that the
number of PVs showing reflux increases with more and
advanced chronic vein disease.15,16,23 Reflux must be
measured preferably in the relaxation phase after distal
compression.14 The duration of reflux as a criterion of
incompetence varies from 0.3 seconds24 to 1 second,25
but most authors consider reflux of more than 0.5
second as evidence for incompetence.23,26–29 Concern-
ing the diameter, it has been shown that IPVs have a
bigger diameter than competent ones.15,23,26 Although
several authors consider a certain diameter predictive
of pathologic reflux,7,10,15,16,26 most authors agree
that the diameter should not be a criterion to decide
whether a PV is competent or incompetent.25 Other
criteria to describe IPV have also been proposed: In a
prospective study by duplex ultrasonography of 265
PVs in 90 legs, Delis23 concluded that criteria to
discriminate between competent and IPVs are not only
reflux and diameter, but also peak and mean velocities,
volume flow, time to peak velocity, and venous volume
displaced outward. It is clear that more research is
needed in order to develop criteria to define and grade
incompetence of PVs, using reflux time, number of
IPVs, diameter, and several other criteria.
Based on the different pathogenetic ways, PVs may
become incompetent; several authors have developed a
clinical classification of IPVs. They base this classifica-
tion on the presence of IPV and reflux in other
segments of the venous systems.30–33 In summarizing
these classifications, one might conclude that there are
five clinical different types of IPVs (Table 1).
IPV I: Primary Type
In this case, there is a primary insufficiency of a PV,
probably caused by an inherited weakness of the vein
wall.34 This IPV leads to an insufficient superficial
venous segment distal of this IPV. Varicose veins
occurring from such a primary IPVs are known as
‘‘perforans varicose.’’35 IPV I are found along the GSV
pathway and can cause significant reflux, resulting in
medium-sized distal varicositas.36 One might consider
primary incompetence of the saphenofemoral and
parvapopliteal junctions as IPV I. Primary incompe-
tence of the Hunterian perforator vein can also be
considered as an IPV I and is known as a common
cause of medial thigh varicose veins in patients with a
competent saphenofemoral junction.19 In fact, Fegan37
already described in 1963 that saphenovarices have
been found to disappear after injection of an incom-
petent Hunterian ‘‘communicating’’ vein. Another
example of IPV I is primary incompetence of the PV
of Boyd. This IPV is considered by some authors as the
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most common side for spontaneous occurrence of a
primary varicose vein.19
IPV IIa: Secondary to Varicositas, No Evidence of
Deep Venous Reflux
The PV becomes incompetent as a result of a proximally
located insufficient superficial venous system. Hach35
studied the function of PV in the so-called private
circulation (privatkreislauf-rezirkulationskreise), a con-
cept that was first introduced by the surgeon Trendelen-
burg.38 Hach stated that in case of reflux in the
superficial system, the deep venous system becomes
overloaded. In the early stage, compensation is possible
via a private circulation: The blood will re-entry the
superficial system through distal competent PVs. These
so-called re-entry PVs are considered useful for drainage
and cannot be considered as pathological.39 They show
bidirectional flow, with a resultant flow inward.12,39
Hach35 defined this situation as a ‘‘compensated’’ private
circulation. When this situation continues to exist, the
deep system will become too much overloaded and the
distal re-entry PV can become incompetent. IPVs are
most likely to be found in association with (correctable)
superficial reflux disease,40 and therefore, the most
common type of IPV is type IIa.15,30
IIb: With Evidence of Deep Venous Reflux
Whenever the superficial reflux and the secondary IPV
continue to exist, a secondary insufficiency of the
popliteal and femoral veins will develop, and the clinical
picture of CVI will become clear. In this situation,
Hach35 spoke of an ‘‘decompensated’’ private circula-
tion. It is known that deep vein reflux accompanies
saphenous reflux in 20% of limbs with varicose veins.41
Type IIb is the second most common type of IPV.30
IPV IIIa: IPV as a Result of Posttrombotic
Syndrome, Thrombosis Not Recanalized
In this situation, the IPV acts as part of a collateral
pathway for deep venous obstruction.
IIIb: Thrombosis Recanalized
The deep venous reflux (as a result of the thrombosis)
can cause incompetence of the PV.
IPV IV: IPV in Association With Isolated Deep
Reflux
This IPV is found with deep venous reflux, caused by
primary valvular incompetence.
IPV V: Isolated Type
No other venous reflux is found. This type of IPV is
rare.16,42,43 The question is whether the reflux in these
PVs is physiologic.
Diagnostic Methods
How can we detect IPVs? Clinical examination alone is
not reliable to detect IPVs, although IPVs can present as
Table 1. Clinical Classification of IPVs (After Stuart, Clerici, Saharay, Rabe)
Definition Coexisting Venous Problems Example Therapy Recommended?
IPV I Primary insufficient PV Varicosis distal of IPV Saphenofemoral junction Yes
Parvapopliteal junction
Perforators of the femoral canal
(Hunter or Dodd PV)
Paratibial Perforators
(Boyd or Sherman PV)
IPV II IPV as distal terminal point of
proximal varicosis (recirculation)
Varicosis proximal of IPV Reflux in GSV with distal IPV Treatment of superficial
reflux first
IIa No deep venous reflux
IIb Deep venous reflux Deep venous reflux Reflux vena femoralis Treatment of IPV unknown
IPV III IPV in patients with thrombosis in
deep venous system
Thrombosis Treatment of IPV unknown
IIIa Thrombosis not recanalized No
IIIb Thrombosis recanalized Treatment of IPV unknown
IPV IV IPV with isolated deep venous reflux
(primary valvular incompetence)
Deep venous reflux Probably useful in case of
clinical symptoms
IPV V Isolated IPV No other venous problem IPV I without yet varicosis Yes, unless considered as
physiologic
Dermatol Surg 29:9:September 2003 VAN NEER ET AL.: VENAE PERFORANTES 933
blowouts, and on palpation, a rather painful fascia
defect can be found.31 These ‘‘clinically detected
perforators’’ are often confused with simple ampullary
dilation of a varicose segment.78 During surgical
exploration, surgeons found that these clinically de-
tected ‘‘perforators’’ showed often no evidence of a
related IPV.79,80
IPV can be detected with continuous wave (CW)
Doppler, but CW Doppler has no advantage over
clinical examination.81 Compared with Duplex, CW
Doppler has a low sensitivity (29%) and low
specificity (15%) in detecting IPVs.27 Nowadays, CW
Doppler is not considered a reliable method to
diagnose IPV.27,78,81,82
Ascending phlebography and varicography are
valuable for detecting perforator incompetence. Diag-
nosis of an IPV is made when contrast is seen to pass
from deep to superficial system. Further radiographic
features of an incompetent communicating vein are
dilation, irregularity, and peripheral tortuosity. There
have been several studies in which phlebography
of IPV has been compared with surgery. Considering
findings at surgical exploration as 100%, phlebogra-
phy was able to detect 65%83 to 90%84 of IPV.
Although many investigators consider surgical ex-
ploration as reliable, a common definition of an IPV
found at surgical exploration is not available. When
compared directly with full-calf exploration at surgery,
ascending venography identifies approximately 80%
of IPV.85,86 The addition of varicography to venogra-
phy identifies 90% of IPV.84,85
Duplex ultrasound sonography has become the
method of choice in detecting IPV in recent years. It
is noninvasive, well tolerated, easy to perform, and
cost effective. With Duplex, PVs can be visualized. The
diameter can be measured, and the direction of flow
can accurately be seen and described.14 One disadvan-
tage could be that PVs that are smaller than 1 mm in
diameter are difficult to visualize and measure flow
within them, although it is not certain whether PVs of
this size are clinically or hemodynamically relevant.
The accuracy of Duplex for the diagnosis of IPV of the
Cockett group is comparable to phlebography.87 In
one prospective study, Duplex was even more effective
to detect IPVs compared with surgery than phlebo-
graphy was.83 A number of other studies have been
performed in which preoperative Duplex investigation
of IPV has been compared with intraoperative find-
ings. Again, no reliable definition of IPV at surgical
exploration is known. Good correlations between
preoperative Duplex and intraoperative findings have
been found.83,87,88 Philips et al.84 and Pierik et al.28
could not confirm this. Philips performed a prospective
study at 93 patients with IPV and varicosis. In only
60%, the findings of IPV by Duplex could be
confirmed intraoperatively. The sensitivity of Duplex
in this study could not be assessed because surgical
exploration was only done when abnormalities were
demonstrated by either Duplex or venography. Pierik
et al.28 investigated 42 patients with venous ulceration
and found a specificity of Duplex of 100% and a
sensitivity of 79%. However, they ligated any PV seen
at surgical exploration, without knowing or defining
whether they were incompetent.
Most phlebologists consider duplex ultrasound as
the method of choice to detect IPV, despite the fact that
Duplex provides only reliable anatomical information
and limited functional data. A test in which topo-
graphic assessment along with functional evaluation is
performed would be most welcome in order to predict
treatable perforators.
Role of IPVs in venous disease
In general, it is difficult to isolate the significance of PV
incompetence from the significance of coexisting
venous disease.22,43,44 This is also true if we study
the effects of interruption of IPV because patients
operated for IPV are often operated simultaneously on
the superficial venous system and we know that reflux
eliminating surgery in one part of the venous system
can abolish reflux in another part.45,46
Hemodynamic Role of IPV
Studies about the hemodynamic importance of IPVs in
venous disease have been performed. Bjordal12,13
examined patients with primary varicosis with simul-
taneous pressure and flow recording. His conclusion
was that in primary varicosis, IPVs have no hemody-
namic significance. The number of patients was low
(6 and 21), and the diagnosis of incompetence was
made by clinical examination alone. Zukowski et al.47
also studied the role of IPV in 180 patients with
superficial varicosis without deep venous disease. In
only 70 patients, IPVs in the calf could be found. On
basis of AVP after calf muscle exercise and venous
refilling time, 35% of these IPVs were found to be of
major hemodynamic importance and another 35% of
moderate haemodynamic importance. The authors
suggest to differentiate between hemodynamic impor-
tant and nonimportant IPVs before treating them.
McMullin et al.48 investigated the isolated hemody-
namic consequences of dysfunction of the deep,
superficial, and also the perforating system in 90 limbs
of patients with clinical signs and symptoms of CVI in
at least one limb. A definition of CVI is not given.
Duplex scanning, ascending venography, and AVP
were performed. Of the 90 limbs, 17 were found to
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have no abnormalities of the deep or superficial veins
on duplex scanning despite severe symptoms (history
of ulcer, lipodermatosclerosis, swelling, varicose veins,
or active ulcers), and on ascending venography, all of
these limbs showed at least two IPVs. Their conclusion
was that these symptoms were due to IPV alone, and
hemodynamic function test showed that there was a
significant difference in these patients compared with
those without any objective venous problem.
The hemodynamic effect of ligation of IPV in
patients with superficial venous incompetence has also
been studied. Fitridge et al.49 performed a prospective
randomized trial evaluating the hemodynamic role of
calf IPV. They investigated 38 limbs with uncompli-
cated varicose veins with both long saphenous and calf
perforator incompetence but without evidence of deep
vein incompetence. Saphenofemoral junction ligation,
stripping of the long saphenous vein to the knee, and
stab avulsions of any visible varicosities in the leg were
performed. Patients were randomized to have the
incompetent calf perforators ligated or left intact.
Hemodynamic function was evaluated with air
plethysmography preoperatively and 2 months post-
operatively. No significant hemodynamic difference
was demonstrated between the two groups. Their
conclusion was that there is no additional hemody-
namic advantage of perforator ligation in patients with
uncomplicated varicose veins at follow-up at 3
months. The number of patients investigated, however,
is rather low, and the follow-up period is short.
Rhodes et al.50 performed subfascial endoscopic
perforator vein surgery (SEPS) on 31 legs in patients
with advanced CVI. Of these patients, 77% revealed
deep venous reflux on preoperative Duplex scanning.
In 30 legs, the superficial system was operated
simultaneously (stripping, crosse-ectomy, or stab-
avulsion). SEPS alone was performed in one limb
only. Strain-gauge plethysmography was performed
preoperatively and 6 months after. To analyze the
relative contribution of perforator ligation, two groups
were formed: one group in which SEPS was performed
with high ligation with or without saphenous stripping
(n524) and one group (n57) in which SEPS was
performed with avulsion of varicosities in six patients
and SEPS alone in one patient. Improvement of calf
muscle pump function and venous incompetence
reached statistical significance in group 1 only, the
group in which the superficial reflux was also
operated. Clinical score and outcome, however,
improved statistical significant in both groups.
The hemodynamic role of IPV in patients with deep
venous incompetence has also been investigated. Deep
venous incompetence can be caused by primary
valvular incompetence or by thrombosis of the deep
veins. Several studies showed no statistical significant
hemodynamic improvement of venous function after
perforator ligation in post-thrombotic legs.34,51–54 The
number of patients in these studies is low. One study50
showed a significant hemodynamic improvement of
SEPS in patients with primary valvular incompetence
and no significant hemodynamic improvement in post-
thrombotic patients.
IPVs and Venous Ulceration
Venous ulceration develops whenever the calf muscle
pump, necessary to maintain venous return against the
force of gravity, fails.55 This calf pump failure leading
to venous hypertension may occur in patients with
varicose veins and in patients with deep venous
incompetence.56 It is not known what the exact role
of IPV is in the development of venous ulceration. The
association of IPV with venous ulceration was
observed in classic studies of Linton,7 Cockett and
Jones,8 and Dodd and Cockett.57 Although IPVs, in
combination with other venous pathology, were found
frequently in patients with venous ulceration (40% to
60%),15,58,59 isolated perforator vein incompetence is
found in less than 5%58–60 to 8.4%.42 In nearly half
of the patients with venous ulceration, no evidence of
IPV (or other venous disease) was found within 2 cm of
the ulcer periphery.42 All of these studies used duplex
ultrasonography to detect IPV. The possible (impor-
tant) influence of IPV on venous ulcers is indicated by
the results of perforator surgery at patients with
venous ulceration. Some studies show low recurrence
rates24,61 and shorter ulcer healing time compared
with conservative care. De Palma and Kowallek62
showed in a crossover study that failure of conserva-
tive care could be reversed by intervention with
sectioning of PVs. The number of patients was low
(10), and in 70%, stripping of the long saphenous vein
was performed simultaneously. It is also known that
sclerotherapy of periulcer varices and perforators can
significantly improve local venous hemodynamics and
speed ulcer healing.63 Unfortunately, in most of these
studies, superficial venous reflux was treated before or
simultaneously with ligation of IPV. It is known that
ablation of superficial venous reflux alone in patients
with venous ulceration shows a good ulcer healing
(80% to 90% after 18 and 42 months, respec-
tively),60,64 and therefore, the effect of perforator
ligation is difficult to interpret. The study of Proebstle
et al.54 shows the importance of incompetence of the
superficial venous system in venous ulceration: They
performed SEPS on 16 patients with venous ulceration.
They selected patients that had already received
stripping or ligation of incompetent superficial veins.
In their series, only 56% of the ulcers healed after 56
days, which is lower than the usual healing rates with
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SEPS (88% after 1 year61 and 92% after 3 months65).
It must be noted, however, that they only treated those
IPVs that had been detected preoperatively by Duplex
or phleboradiography instead of treating all visible
PVs (competent or incompetent), as is the normal
procedure in SEPS. The presence of deep venous
incompetence was found to be a useful indicator of
ulcer recurrence.66 Unfortunately, the etiology of this
incompetence (postthrombotic or primary valvular
incompetence) was not documented in this study.
Several studies show that healing is slower and/or ulcer
recurrence is higher in legs with postthrombotic deep
venous incompetence compared with legs without
deep venous incompetence,61,67,68 although clinical
improvement can be significant even in this group.50 In
legs with deep venous incompetence caused by
primary valvular incompetence, there is a significant
improvement of ulcer healing and recurrence rate after
ligation of IPV.50,61
IPVs and Superficial Varicosis
As stated before, IPV I can be a cause of varicosis, and
IPV II can be the result of varicosis. There are several
studies on the presence of IPV in patients with
recurrent varicosis. Most studies show a high
prevalence of IPV in patients with recurrent varicose
veins after surgery,6–74 especially incompetent thigh
PVs.37,75,76,77 Although there seems to be an association
between IPV and recurrent varicose veins, it is now
essential to establish whether this is a causative link.73
Therapy
Whether perforators should be dealt with at all
remains a controversial question. Several authors are
rather sceptical about the need for treatment.10,22,89
They consider PVs in the leg as a part of a
compensatory mechanism contributing to venous
return.39 It has been described that IPVs can be found
in a greater number after correction of the raised
superficial venous pressure,69–74 probably as a
consequence of the new hemodynamic and patho-
physiologic scene.39 Some authors have shown that
selective ligation of IPVs, in absence of deep venous
reflux, does not improve venous hemodynamics.49,50
Most studies on treatment of IPV treat the superficial
system as well,90 and because we know that correction
of superficial reflux leads to correction of pathological
outward flow in PVs in most cases (80%),30,31,64,91 it
is almost impossible to judge the effect of ligation of
IPV alone. According to Stuart et al.,30 much of the
controversy about the appropriateness of perforator
ligation could be caused by differences in case mix and
selection between series. Several authors proposed to
differentiate between clinical types of IPV when
selecting patients for perforator therapy.30–33
Referring to the former classification (Table 1), we
can try to formulate a therapeutic strategy.
IPV I
All authors agree that this type of IPV needs to be
treated in order to prevent recurrence of the superficial
venous insufficiency distal of the IPV.92
IPV IIa
Correction of proximal superficial reflux is considered
to be the first therapeutic step and is of great
importance. The venous refill time recovers dramati-
cally,90 and the IPVs become competent in most cases
(80%),30,91,93 with the best effect on the PVs above the
knee.91 Correction of reflux in the GSV has shown to
reduce the diameter of lower leg perforators30 until 6
months after operation.94 It is not known whether the
remaining 20% of the IPVs have any hemodynamic
importance.33,39
IPV IIb
Two studies45,46 showed that surgical eradication of
superficial venous reflux (GSV) can correct reflux in
the deep veins, a finding confirmed by others,94 and
thus, it is worthwhile to correct the saphenous reflux,
even in patients with deep venous reflux.
If the deep venous reflux does not disappear after
superficial correction, it is unknown whether this IPV
should be treated. However, the IPV could still be
(functional) relevant, and thus, most authors tend to
treat these IPVs,30,33 especially when skin changes are
present.31
IPV IIIa
All authors agree that this type of IPV should not be
treated. This IPV function as an ‘‘escape’’ possibility.
Treatment would deteriorate the venous pathology.
IPV IIIb (Thrombosis Recanalized)
The benefit of treatment of IPV in patients with post-
thrombotic deep venous incompetence remains un-
proven by controlled data.32,33,41,67
IPV IV
In patients with IPV and primary valvular incompe-
tence, it seems to be appropriate to treat these IPV.50,61
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IPV V
Because we do not know whether these IPVs are
functional, it is unknown whether this type of IPV
should be treated. According to some authors, there
are special indications in which treatment of IPV could
be of benefit: patients who have highly symptomatic
CVI (pain),79 patients who have threat of ulceration or
have recurrent refractory ulceration,95 patients with
elective localization of trophic lesions over IPVs, and
cases of secondary skin changes with CVI Widmer II of
III.31 Treatment of IPV has also been recommended in
nonsaphenous varices.95
Method of Treatment of IPV
Whenever the decision has been made that treatment of
IPV is necessary, there are different techniques possible.
Surgery
Linton7 was the first to suggest and perform ligation of
IPVs. Before the ligation of the PVs, high ligation of
incompetence GSV and short saphenous vein should be
performed. His perforator operation, called Linton’s
procedure, required a long skin incision, and wound
complications were frequently noted. Is it now widely
accepted that open perforator ligation, like the
Linton’s procedure, is associated with an unacceptable
level of morbidity, and therefore, these procedures
have largely been abandoned.30,89,104
Queral and Criado96 performed a ‘‘purse-string’’
permanent suture technique for IPVs. The procedure is
easy to perform and has very encouraging early results.
The recurrence rate of venous ulceration is low. Queral
and Criado stated that this technique is valuable in the
treatment of patients with venous ulceration asso-
ciated with incompetent calf perforators.
SEPS
In recent years, SEPS has rapidly developed at a
minimally invasive technique to interrupt PVs.97 The
technique is as follows: Through a small incision in the
upper calf, away from the skin with lipodermato-
sclerosis or ulceration, an endoscope is introduced
between the fascia and the underlying muscle. The
instrument is advanced down to intercept all visible
PVs, which may be clipped, treated with diathermy, or
simply cut.89 Edwards98 was the first to introduce the
‘‘phlebotome’’ for blind sectioning of leg perforators,
using only a small incision at the upper part of the leg,
outside areas affected by lipodermatosclerosis. In
1985, Hauer99 used a mediastinoscope or rigid
proctoscope to insert under the medial superficial leg
aponeurosis. The technique has been refined since then
with the introduction of endoscopy, insufflation of
CO2 (two-channel technique), external retraction
technique,100 and the video endoscopy.101 Advantages
of SEPS are that compared with the classic perforator
surgery techniques, SEPS is associated with signifi-
cantly less morbidity, smaller scars, and a shorter
hospital stay.24,102–104 Complications of SEPS are low.
Wound complications occur in 4% to 6%.105 Deep
vein thrombosis occurs occasionally.103 Pain (1.5%)
and paresthesia (6%) can also occur, especially when
using the electrocautery in the subfascial space.106
Case reports of iatrogenic leg ulcer107 and arteriove-
nous fistula108 have been reported. A disadvantage of
SEPS is that it is more cost-effective in healing venous
ulcers compared with compression bandaging.109 SEPS
is mostly performed in patients with venous ulceration
(with active or healed venous ulceration C5 and C6). It
is usually performed in combination with ablation of
the superficial venous reflux and is considered success-
ful in the treatment of venous leg ulceration. Several
short- and mid-term clinical series have validated high
healing rates (84% to 100%) and low recurrence rates
(recurrences at 2 years, 0% to 22%).24,54,61,65,110
Compared with the results of conservative treatment
of venous leg ulceration (recurrence rate of 29%111 to
66%112), this is clinically highly relevant. Reliable
long-term results of SEPS compared with (modified)
Linton procedure are not available, although they
seem to be comparable.24
In patients with venous ulceration and deep venous
reflux, the effect of surgical treatment of IPV over
optimal medical management needs to be further
investigated.24,61 A significant higher ulcer recurrence
rate after SEPS is found in the postthrombotic
group.52,61 However, the clinical benefit of SEPS was
evident in this group even in patients with persistent or
recurrent ulcers.61 Even in patients with postthrombo-
tic syndrome, SEPS showed a reduction in disease-
related symptoms (pain and oedema), improved
hemodynamics in almost 60%, and facilitated healing
of long-lasting ulcers.54 Despite this clinical improve-
ment, the long-term effects of SEPS in patients with
venous ulceration and deep venous incompetence are
not clear: Sybrandy et al.24 found a high number of
newly developed PVs 4 years after performing SEPS.
This finding was significantly influenced by the
presence of deep venous incompetence. Unfortunately,
there is no specification about the origin of this deep
venous incompetence (primary valve incompetence or
post-thrombotic). A possible explanation for this
phenomenon could be that persistent high venous
pressure in the calf causes new IPVs to develop.24 The
role of SEPS in venous insufficiency with only skin
symptoms (no ulceration) remains controversial.
Encouraging results have been published using SEPS
(combined with phlebectomy and partial of complete
stripping of GSV) in the treatment of recurrent
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varicose veins and CVI.105 More prospective, rando-
mized trials are needed to evaluate the effect of SEPS
on primary varicosis and CVI.113
Ultrasound-guided percutaneous coil embolisation
of IPV has been investigated but proved to be
ineffective for treatment of venous ulcers and recurrent
varicosities.114
Sclerotherapy
No consensus has yet been reached about the role of
sclerotherapy of IPV.115–117 There are only a few good
studies on the effect of sclerotherapy for IPVs of the
lower legs (Table 2). Fegan37 described in 1963 the
technique of injection into superficial veins adjacent to
the IPV with the leg raised and applying immediate
compression afterward. He used 0.5-ml sodium tetra-
decylsulfate (STDS) 3%. No conclusions from this
study can be drawn because detection of IPV was
performed by clinical examination alone.
In a comprehensive study comparing surgery and
sclerotherapy, Hobbs93 concluded that the best pri-
mary treatment for IPV in the lower part of the legs
was injection-compression therapy. His article shows
that after a follow-up period of 6 years, only 20% of
the IPV treated with sclerocompression was cured.
Hobbs also used 0.5- to 0.75-ml STDS 3%. However,
in his article, Hobbs was not convinced that the
injection was always made at the side of the PV and
certainly not directly into it. He used the term ‘‘points
of control’’ rather than ‘‘perforators’’ and stated that
‘‘it is hoped that all IPVs are included.’’
There are two prospective studies on ultrasound-
guided sclerotherapy (USGS) for IPVs: Thibault and
Lewis69 performed an open prospective study on 36
patients. He treated them with 0.5- to 1-ml STDS 3%.
Before treatment, high-risk sites such as calf PVs were
scanned with pulsed Doppler for arterial signs. In
15%, he needed more than one injection. Compression
was applied for 4 weeks. Follow-up at 6 months
revealed 73% to 100% success. The best results were
obtained with injection of incompetent gastrocnemius
PVs. Incompetent thigh PVs were found difficult to
treat if they were small and located more than 2.5 cm
beneath the skin. Thibault and Lewis concluded that
there is need for further refinement of the technically
difficult procedure and need for development of a
needle guide probe attachment to aid precise localisa-
tion of the needle tip at a depth of 0.5 to 3 cm.
Complications like deep vein thrombosis, pulmonary
embolism, or intra-arterial injection were not seen.
In another open prospective study by Schadeck,118
STDS 3% was used to treat IPVs in 51 patients.
Correction of the superficial reflux was first per-
formed. During injection much attention was paid to
avoid entering the PVs because of possible intra- Ta
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arterial injection. Follow-up at 1 to 7 months revealed
92% success in one session and another 8% in two
sessions. No compression was applied. Complications
such as redness, pain, and induration were seen in
40%. No intra-arterial injection, deep vein thrombo-
sis, or nerval damage occurred.
Guex95 stated in his article on USGS for PVs that in
his experience, occlusion of IPV with USGS is obtained in
about 90% of the cases with three or less sessions. Veins
with a diameter of more than 8 mm are more likely to be
resistant to sclerotherapy. In his opinion, future studies
should include preoperative and postoperative diameter
and reflux duration, plethysmographic evaluation of
therapy, and duplex-visible sclerosis of the veins.
Despite this lack of consensus, several authors treat
IPV with sclerotherapy.36 IPV of Hunter20,117 and IPV
of Boyd117 seem to react very well to sclerotherapy.
The results of sclerotherapy of ankle perforators are
less convincing,117 although good results have been
claimed in patients with venous ulcers.119
Complications of sclerotherapy of IPV are equal
to complications that occur with sclerotherapy of
varicose veins: hyperpigmentation, phlebitis, necrosis,
allergy, and intra-arterial injection.120 Hyperpigmen-
tation and phlebitis occur regularly, and the other
complications are rare121 despite the fact that almost
every PV runs with an artery.
It is clear that treatment of IPVs by means of
sclerotherapy needs to be investigated more in the future.
Regarding long-term results, no controlled study and no
data on recurrence rate are available.95 For instance, in
his clinical review on sclerotherapy of varicose veins,
Green122 criticized the short follow-up periods of studies
on sclerotherapy of IPV. In his opinion, 1-year follow-up
is necessary to claim success. USGS seems to be most
promising. In a meeting report on REVAS (recurrent
varices after surgery),123 it is stated that the technique of
USGS of PVs is worth further evaluation.
Discussion
Despite the fact that PVs have been known for a long
time, much knowledge about these veins is still
lacking. For instance, there is a lot of confusion about
the nomenclature of PV. A recent consensus document
suggests a new anatomical classification to locate PVs.
We would recommend every phlebologist to use this
classification. Various authors have tried to make a
clinical classification of IPVs. Summarizing these
clinical classifications, a proposal is done to divide
IPVs in five clinical types (Table 1). Hopefully this
clinical classification will contribute to a perforator
classification analogous to or even integrated in the
CEAP classification.
We know that PVs direct blood flow from super-
ficial to deep veins (inward flow), and we know their
valves are helpful in this procedure. The smaller PVs
(less than 1 mm in diameter) are valveless, and they are
considered of little or no hemodynamic importance. It
is also known that blood can flow from the deep to the
superficial system as well (outward flow or reflux).
This bidirectional flow can occur in patients with
venous disease but also in healthy persons. It is not
understood what the meaning of this reflux in healthy
persons is. Do we have to consider this as a physiologic
phenomenon, or is this reflux the beginning of venous
disease? It would be very interesting to follow over
time these healthy persons with reflux in their PVs to
see whether they develop venous symptoms.
There is no good definition of IPVs. The mostly used
criterion of incompetence is reflux of more than 0.5
seconds, best detected by means of Duplex ultrasono-
graphy. Most phlebologists agree on the fact that if a
PV shows no reflux, it has no hemodynamic signifi-
cance. Although it has been shown that IPVs have
bigger diameters than competent ones, this is not
regarded as a good criterion to define incompetence.
We need more sensitive and specific measure techni-
ques in order to discriminate between physiologic and
pathologic reflux, and we certainly need more criteria
to define and grade incompetence of PVs. We probably
need a functional test as well, and maybe we ought to
take clinical findings into account to define incompe-
tence.
What exactly is the role of IPV in venous disease?
Results of hemodynamic studies are conflicting but
show that IPVs can be of hemodynamic significance. In
general, it is difficult to isolate the significance of PV
incompetence from the significance of coexisting
venous disease. There are no good studies that
investigate solely the role of IPVs in venous disease.
This is unfortunate because we know for instance that
in patients with superficial reflux and IPV, correction
of this superficial reflux causes most of the IPVs to
become competent. Thus, whenever we want to study
the influence of IPVs, any coexisting superficial reflux
should be dealt with beforehand.
In the development of venous ulceration, there
could be a role for IPVs because epidemiologic studies
show that IPVs are found in 60% of patients with
venous ulceration. It is difficult to interpret the
significance of IPVs in venous ulceration from the
results of SEPS because not only are most surgeons
dealing with superficial reflux at the same time as they
perform SEPS but also all PVs seen during the
operation are ligated, whether they are incompetent
or not. After SEPS procedures, IPVs can persist, or
even new IPVs can develop. SEPS is performed
successfully in patients with active or healed venous
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ulceration (C5, C6) but remains controversial in
patients with only skin symptoms.
Primary insufficiency of a PV can cause varicosis. A
good example is primary incompetence of the Hunterian
perforator as a common cause of medial thigh
varicosis in patients with a competent saphenofemoral
junction. There is a high prevalence of IPVs in patients
with recurrent varicose veins, and we know that IPVs
can be a cause of recurrent varicosis. A good example
is the IPV of Boyd, which can cause recurrent varicosis
of the GSV of the lower leg after a short strip of the
GSV, although some surgeons tend to treat the IPV of
Boyd during a short strip procedure.
Regarding therapy of IPV, it is important to take the
clinical types into account: IPV I (primary type) and
IPV IV (IPV with isolated deep venous reflux caused by
primary valvular incompetence) can be dealt with. In
case of IPV II (IPV secondary to a varicose vein, with
or without deep venous reflux), it is necessary to treat
the superficial reflux first. Whether the remaining IPV
should be dealt with is unknown. IPV IIIa (IPV with
thrombosis, not recanalized) should not be treated. No
controlled data are available for the justification of
treatment of IPV IIIb. IPV V (isolated type) could be
physiologic, and thus, treatment is most probably
inappropriate unless clear clinical signs are present.
There are two important treatment options for IPV:
surgery and sclerotherapy. SEPS has become a popular
surgical technique to treat IPVs. SEPS (together with
ablation of superficial reflux) seems to be appropriate
in patients with venous ulceration and advanced CVI,
although level 1 evidence is still lacking. Short-term
results show that SEPS is certainly preferable to the
classic Linton’s procedure. In patients with deep
venous incompetence, hemodynamic improvement
with SEPS is seen in only the patients with primary
valvular incompetence and not in patients with post-
thrombotic syndrome, although clinical symptoms can
improve in these patients as well. The development of
new IPVs 4 years after SEPS is worrying, and the
implications of this finding need to be investigated
more thoroughly.
The effect of sclerotherapy on IPV has been
investigated by several authors. It certainly causes less
complications then any surgical therapy. Until now, no
controlled data and certainly no reliable long-term
results are available. Nevertheless, sclerotherapy of
IPVs, especially USGS, is promising and needs further
evaluation.
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Commentary
In this meticulously researched and carefully crafted article, the
authors probe the relationship of PVs to venous abnormalities
that faces phlebologists on a daily basis. Of particular
importance is their attempt to determine the role of IPVs in
the production of venous disease as well as formulating both a
rationale for therapy and an analysis of currently employed
treatment techniques. In addition, this monograph presents
what may be the most logical and succinct classification
protocol to date. The authors are to be congratulated.
DAVID M. DUFFY, MD
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